This framework and its accompanying toolkit are designed to help the Joint Programme support countries and communities in their efforts to identify HIV-related inequalities and their drivers and to address them according to the Joint Programme’s comparative advantages and capacity—and, in doing so, support the full realization of human rights.

The Compendium documents 41 promising practices that provide evidence of the core roles that faith communities have played in identifying undiagnosed children living with HIV, improving continuity of treatment, supporting adolescents to access psychosocial support, care and treatment, and enabling peer support groups to empower children and adolescents living with HIV. Also available: Feature story | Executive summary | Portuguese

The Global HIV Prevention Coalition focus countries are progressing unevenly towards the goal of reducing HIV infections to levels that would no longer constitute a public health threat. The biggest declines are occurring in eastern and southern Africa and, to a lesser degree, in western and central Africa. Expansion of access to effective ART, combined with an ongoing focus on primary prevention, are driving those achievements.

In 2024, five years later, the data show that people who inject drugs are still being left behind in the response. In 2022, the global median HIV prevalence among people who inject drugs was 5% across 50 reporting countries, seven times higher than among the rest of the adult population (aged 15–49 years). This figure hides significant geographical and population-based disparities. Among reporting countries, HIV prevalence ranged from 0% to 51%. Among the 16 countries with gender disaggregated data, the reported median HIV prevalence among men who inject drugs was 9%, while it was nearly double (15%) among women who inject drugs.

The Code of Conduct applies to any UNAIDS event or gathering, which shall include but is not limited to meetings, conferences and symposia, assemblies, receptions, scientific and technical events, expert meetings, workshops, exhibits, side events, and any other forum organized, hosted or sponsored in whole or part by UNAIDS. Such UNAIDS event or gathering, whether it is organized, hosted, or sponsored by UNAIDS, may take place in person or online, within/on or outside UNAIDS premises.

This study aims to review costing methods applied across strategic planning documents to better understand
the variation in approaches, identify common methodological strengths and
weaknesses, and propose tools that can support improvements in the form of a
guideline and a reporting checklist.

This brief, the third in a series of three, discusses the ethical issues arising from HIV phylogenetic analyses in both research and public health settings and offers guidance on how to minimise risks for analyses that generate sensitive data. The first brief, The Application of Phylogenetics to HIV—Insights into Biology and Epidemiology of HIV, explains the methods and approaches used to generate genetic and phylogenetic data and analyses. The second brief explores what we have learned from HIV phylogenetic studies and how HIV phylogenetics can and should be used to support public health programmes.

This is the second brief in a series of three on HIV phylogenetics. The first brief, The Application of Phylogenetics to HIV—Insights into Biology and Epidemiology of HIV, explains the methods and approaches used to generate genetic and phylogenetic data and analyses. This brief summarises the ways in which phylogenetic (and other sequence-based) analyses are currently being used and reflects on how they could be used in the future in the field of HIV research and public health. The third brief discusses the ethical challenges of using HIV phylogenetics in research and public health surveillance.